2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the american college of cardiology foundation/american heart association task force on practice guidelines

Heart Rhythm

Volumn 9, Issue 10, 2012, Pages 1737-1753

  Tracy, Cynthia M ^a   Epstein, Andrew E ^a   Darbar, Dawood ^a   Dimarco, John P ^a   Dunbar, Sandra B ^a   Estes III, N A Mark ^a   Ferguson, T Bruce ^a   Hammill, Stephen C ^a   Karasik, Pamela E ^a   Link, Mark S ^a   Marine, Joseph E ^a   Schoenfeld, Mark H ^a   Shanker, Amit J ^a   Silka, Michael J ^a   Stevenson, Lynne Warner ^a   Stevenson, William G ^a   Varosy, Paul D ^a  

^a NONE

Author keywords

ACC Practice Guideline; arrhythmias; cardiac resynchronization therapy; focused update; heart failure; pacemaker

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; DEVICES; FOLLOW UP; HEART ARRHYTHMIA; HEART PACING; HEART RHYTHM; HEMODYNAMICS; HUMAN; MEDICAL SOCIETY; MONITORING; PACEMAKER; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AMERICAN HEART ASSOCIATION; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84866667746     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.08.021     Document Type: Article

References (69)

1. ACCF/AHA Task Force on Practice Guidelines Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines American College of Cardiology Foundation and American Heart Association, Inc 2010 http://assets.cardiosource.com/Methodology-Manual-for-ACC-AHA-Writing- Committees.pdf http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/ documents/downloadable/ucm-319826.pdf Accessed May 16, 2012
2. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine Finding What Works in Health Care: Standards for Systematic Reviews 2011 The National Academies Press Washington, DC
3. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine Clinical Practice Guidelines We Can Trust 2011 The National Academies Press Washington, DC
4. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) J Am Coll Cardiol 51 2008 e1 e62
5. B.J. Gersh, B.J. Maron, R.O. Bonow 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e212 e260
6. M.J. Ackerman, S.G. Priori, S. Willems HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies Heart Rhythm 8 2011 1308 1339
7. J.M. Horner, M. Kinoshita, T.L. Webster Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience Heart Rhythm 7 2010 1616 1622
8. P.J. Schwartz, C. Spazzolini, S.G. Priori Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry Circulation 122 2010 1272 1282
9. C.I. Berul, G.F. Van Hare, N.J. Kertesz Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients J Am Coll Cardiol 51 2008 1685 1691
10. A. Barsheshet, P.J. Wang, A.J. Moss Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) J Am Coll Cardiol 57 2011 2416 2423
11. M.J. Silka, Y. Bar-Cohen Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator Circ Arrhythm Electrophysiol 1 2008 298 306
12. P. Khairy, L. Harris, M.J. Landzberg Implantable cardioverter- defibrillators in tetralogy of Fallot Circulation 117 2008 363 370
13. A.E. van der Hulst, V. Delgado, N.A. Blom Cardiac resynchronization therapy in paediatric and congenital heart disease patients Eur Heart J 32 2011 2236 2246
14. R. Lampert, D.L. Hayes, G.J. Annas HRS expert consensus statement on the management of cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy Heart Rhythm 7 2010 1008 1026
15. B.L. Wilkoff, A. Auricchio, J. Brugada HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations Heart Rhythm 5 2008 907 925
16. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
17. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
18. J.G.F. Cleland, J.-C. Daubert, E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
19. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 119 2009 e391 e479
20. A.J. Moss, W.J. Hall, D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
21. A.S.L. Tang, G.A. Wells, M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
22. C. Linde, W.T. Abraham, M.R. Gold Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
23. M. Brignole, M. Gammage, E. Puggioni Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation Eur Heart J 26 2005 712 722
24. M. Brignole, G. Botto, L. Mont Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial Eur Heart J 32 2011 2420 2429
25. R.N. Doshi, E.G. Daoud, C. Fellows Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study) J Cardiovasc Electrophysiol 16 2005 1160 1165
26. M. Gasparini, A. Auricchio, F. Regoli Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation J Am Coll Cardiol 48 2006 734 743
27. S.B. Wilton, A.A. Leung, W.A. Ghali Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis Heart Rhythm 8 2011 1088 1094
28. B.L. Wilkoff, J.R. Cook, A.E. Epstein Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial JAMA 288 2002 3115 3123
29. E. Adelstein, D. Schwartzman, J. Gorcsan 3rd, S. Saba Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization J Cardiovasc Electrophysiol 22 2011 905 911
30. M.A. Vatankulu, O. Goktekin, M.G. Kaya Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices Am J Cardiol 103 2009 1280 1284
31. J. Rickard, M. Bassiouny, E.M. Cronin Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology Am J Cardiol 108 2011 1576 1580
32. P.G. Masci, M. Marinelli, M. Piacenti Myocardial structural, perfusion, and metabolic correlates of left bundle branch block mechanical derangement in patients with dilated cardiomyopathy: a tagged cardiac magnetic resonance and positron emission tomography study Circ Cardiovasc Imaging 3 2010 482 490
33. A. Kashani, S.S. Barold Significance of QRS complex duration in patients with heart failure J Am Coll Cardiol 46 2005 2183 2192
34. H.C. Doval, D.R. Nul, H.O. Grancelli Randomised trial of low-dose amiodarone in severe congestive heart failure: Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet 344 1994 493 498
35. G.B. Bleeker, M.J. Schalij, S.G. Molhoek Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure J Cardiovasc Electrophysiol 15 2004 544 549
36. J.J. Blanc, Y. Etienne, M. Gilard Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study Circulation 96 1997 3273 3277
37. F.W. Prinzen, K. Vernooy, B.W.L. De Boeck Mechano-energetics of the asynchronous and resynchronized heart Heart Fail Rev 16 2011 215 224
38. H. Ukkonen, J. Sundell, J. Knuuti Effects of CRT on myocardial innervation, perfusion and metabolism Europace 10 Suppl 3 2008 iii114 iii117
39. S. Cazeau, C. Leclercq, T. Lavergne Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880
40. C. Stellbrink, O.A. Breithardt, A. Franke Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances J Am Coll Cardiol 38 2001 1957 1965
41. D.J. Bradley, E.A. Bradley, K.L. Baughman Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials JAMA 289 2003 730 740
42. M. Haghjoo, A. Bagherzadeh, A.F. Fazelifar Prevalence of mechanical dyssynchrony in heart failure patients with different QRS durations Pacing Clin Electrophysiol 30 2007 616 622
43. S. Stavrakis, R. Lazzara, U. Thadani The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis J Cardiovasc Electrophysiol 23 2012 163 168
44. I. Sipahi, T.P. Carrigan, D.Y. Rowland Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials Arch Intern Med 171 2011 1454 1462
45. L.A. Saxon, K.A. Ellenbogen Resynchronization therapy for the treatment of heart failure Circulation 108 2003 1044 1048
46. K.C. Bilchick, S. Kamath, J.P. DiMarco, G.J. Stukenborg Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients Circulation 122 2010 2022 2030
47. E.C. Adelstein, S. Saba Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization Am J Cardiol 103 2009 238 242
48. J. Rickard, D.J. Kumbhani, E.Z. Gorodeski Cardiac resynchronization therapy in non-left bundle branch block morphologies Pacing Clin Electrophysiol 33 2010 590 595
49. G.A. Upadhyay, N.K. Choudhry, A. Auricchio Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies J Am Coll Cardiol 52 2008 1239 1246
50. J.F. Beshai, R.A. Grimm, S.F. Nagueh Cardiac-resynchronization therapy in heart failure with narrow QRS complexes N Engl J Med 357 2007 2461 2471
51. R. Ariga, M.H. Tayebjee, A. Benfield Greater three-dimensional ventricular lead tip separation is associated with improved outcome after cardiac resynchronization therapy Pacing Clin Electrophysiol 33 2010 1490 1496
52. J.P. Singh, H.U. Klein, D.T. Huang Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial Circulation 123 2011 1159 1166
53. C. Linde, C. Leclercq, S. Rex Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study J Am Coll Cardiol 40 2002 111 118
54. M.O. Sweeney, F.W. Prinzen A new paradigm for physiologic ventricular pacing J Am Coll Cardiol 47 2006 282 288
55. A.D. Sharma, C. Rizo-Patron, A.P. Hallstrom Percent right ventricular pacing predicts outcomes in the DAVID trial Heart Rhythm 2 2005 830 834
56. J.S. Steinberg, A. Fischer, P. Wang The clinical implications of cumulative right ventricular pacing in the Multicenter Automatic Defibrillator Trial II J Cardiovasc Electrophysiol 16 2005 359 365
57. J. Lindenfeld, A.M. Feldman, L. Saxon Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure Circulation 115 2007 204 212
58. M.S. Amin, A.D. Fox, G. Kalahasty Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis J Cardiovasc Electrophysiol 19 2008 1275 1280
59. W.T. Abraham, J.B. Young, A.R. León Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter- defibrillator, and mildly symptomatic chronic heart failure Circulation 110 2004 2864 2868
60. C. Daubert, M.R. Gold, W.T. Abraham Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 2009 1837 1846
61. J.P. Singh, D. Gras Biventricular pacing: current trends and future strategies Eur Heart J 33 2012 305 313
62. W.G. Stevenson, A.F. Hernandez, P.E. Carson Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee J Card Fail 18 2012 94 106
63. K. Dickstein, P.E. Vardas, A. Auricchio 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Eur Heart J 31 2010 2677 2687
64. S. Dubner, A. Auricchio, J.S. Steinberg ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs) Europace 14 2012 278 293
65. G.H. Crossley, J. Chen, W. Choucair Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers J Am Coll Cardiol 54 2009 2012 2019
66. G.H. Crossley, A. Boyle, H. Vitense The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts J Am Coll Cardiol 57 2011 1181 1189
67. N. Varma, A.E. Epstein, A. Irimpen Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial Circulation 122 2010 325 332
68. P. Mabo, F. Victor, P. Bazin A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial) Eur Heart J 33 2012 1105 1111
69. L.A. Saxon, D.L. Hayes, F.R. Gilliam Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study Circulation 122 2010 2359 2367